D. Boral Capital Reiterates Buy Rating for Enlivex Therapeutics (NASDAQ:ENLV)
D. Boral Capital reissued their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report published on Thursday,Benzinga reports. D. Boral Capital currently has a $13.00 price target on the stock. Separately, HC Wainwright lifted their price target on shares of Enlivex Therapeutics from $6.00 to $7.00 and gave the stock […]
D. Boral Capital reissued their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report published on Thursday,Benzinga reports. D. Boral Capital currently has a $13.00 price target on the stock. Separately, HC Wainwright lifted their price target on shares of Enlivex Therapeutics from $6.00 to $7.00 and gave the stock […]
